High-activity multiple sclerosis in feminizing hormone therapy for gender reassignment
ISSN: 2667-257X
Ano de publicación: 2025
Volume: 7
Páxinas: 100234
Tipo: Artigo
Outras publicacións en: Neuroimmunology Reports
Referencias bibliográficas
- Bove, (2014), Mult. Scler., 20, pp. 1584, 10.1177/1352458514527864
- Chitnis, (2013), Clin. Immunol., 149, pp. 192, 10.1016/j.clim.2013.03.014
- Chitnis, (2018), Mult. Scler., 24, pp. 36, 10.1177/1352458517737395
- Dalal, (1997), J. Immunol., 159, pp. 3, 10.4049/jimmunol.159.1.3
- Filippi, (2018), Nat. Rev. Dis. Prim., 4, pp. 43, 10.1038/s41572-018-0041-4
- Giltay, (2000), J. Clin. Endocrinol. Metab., 85, pp. 1648, 10.1210/jcem.85.4.6562
- Goodman, (2019), Endocrinol. Metab. Clin. North Am., 48, pp. 303, 10.1016/j.ecl.2019.01.001
- Israelit, (2019), Immunology, 156, pp. 9, 10.1111/imm.13004
- Joseph, (2017), J. R. Soc. Med., 110, pp. 144, 10.1177/0141076817696054
- Pakpoor, (2014), Ann. Neurol., 76, pp. 625, 10.1002/ana.24250
- Pakpoor, (2016), Mult. Scler., 22, pp. 1759, 10.1177/1352458515627205
- Sicotte, (2007), Arch. Neurol., 64, pp. 683, 10.1001/archneur.64.5.683